Inventor · disambiguated record
Leonard Buckbinder
Also filed as: BUCKBINDER LEONARD · BUCKBINDER LEONARD R
7 granted patents·15 pending applications·63 citations·filing 1994–2025
82Inventor score
Files withFLAGSHIP PIONEERING INNOVATIONS V INC11BRISTOL MYERS SQUIBB CO3PFIZER2SENDA BIOSCIENCES INC2PFZER INC1
Top patents by PatentIndex Score
22 records- 0190US10953027B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Mar 23, 2021·3 cites·9 claims
- 0276US5840673AInsulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumorsBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Nov 24, 1998·43 cites·4 claims
- 0374US2024180941A1Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 0472US12115178B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Granted Oct 15, 2024·0 cites·9 claims
- 0568US11813272B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Nov 14, 2023·0 cites·9 claims
- 0665US11058698B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Jul 13, 2021·0 cites·2 claims
- 0764US2021283157A1Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 0859US2025295624A1Monomethyl fumarate-carrier conjugates and methods of their useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2025·Application pending·0 cites
- 0959US2021299079A1Monomethyl fumarate-carrier conjugates and methods of their useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 1059US2022296555A1Acylated active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 1159US2022296563A1Acylated active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 1254US5886149AP53 response genesBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Mar 23, 1999·7 cites·3 claims
- 1351US2021085640A1Acylated catechin polyphenols and methods of their use for the treatment of cancerFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Application pending·0 cites
- 1447US2023234967A1Fused Azole Heterocycles as AHR AntagonistsSENDA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1546US5667987AP53 response genesBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Sep 16, 1997·10 cites·22 claims
- 1644US2023295152A1Pyridopyrimidinone derivatives as ahr antagonistsSENDA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1742US2003224349A1Rapid assay to assess the potential for glucocorticoid analogs to promote the differentiation of human osteoblasts and predict bone safetyPFIZER·Filed 2003·Application pending·0 cites
- 1842US2004241755A1Human cell assay to determine effect of sample compounds on Col2 enhancer expressionPFIZER·Filed 2003·Application pending·0 cites
- 1941US2009118316A1Methods for Augmenting BonePFZER INC·Filed 2005·Application pending·0 cites
- 2036US2001049106A1ADAMTS polypeptides, nucleic acids encoding them, and uses thereofFiled 2001·Application pending·0 cites
- 2136US2002090373A1ADAMTS polypeptides, nucleic acids encoding them, and uses thereofFiled 2001·Application pending·0 cites
- 2235US2003166899A1ADAMTS polypeptides, nucleic acids encoding them, and uses thereofFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →